Langerhans cells suppress contact hypersensitivity responses via cognate CD4 interaction and langerhans cell-derived IL-10

Journal of Immunology

Volumn 183, Issue 8, 2009, Pages 5085-5093

  Igyarto, Botond Z ^a   Jenison, Matthew C ^a   Dudda, Jan C ^e,f   Roers, Axel ^b   Müller, Werner ^c   Koni, Pandelakis A ^d   Campbell, Daniel J ^e,f   Shlomchik, Mark J ^g   Kaplan, Daniel H ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

^e BENAROYA RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^g YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CYTOKINE; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL COUNT; CELL INTERACTION; CELL MATURATION; CONTACT ALLERGY; CONTROLLED STUDY; EPIDERMIS CELL; FEMALE; LANGERHANS CELL; MALE; MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SENSITIZATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; DERMATITIS, CONTACT; DINITROFLUOROBENZENE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HOMEODOMAIN PROTEINS; INFLAMMATION; INTERLEUKIN-10; LANGERHANS CELLS; MICE; MICE, MUTANT STRAINS; SKIN; T-LYMPHOCYTES, REGULATORY;

EID: 77349125610     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901884     Document Type: Article

References (50)

1. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
2. Kadyk, D. L., S. Hall, and D. V. Belsito. 2004. Quality of life of patients with allergic contact dermatitis: an exploratory analysis by gender, ethnicity, age, and occupation. Dermatitis 15: 117-124.
3. Wang, B., C. Esche, A. Mamelak, I. Freed, H. Watanabe, and D. N. Sauder. 2003. Cytokine knockouts in contact hypersensitivity research. Cytokine Growth Factor Rev. 14: 381-389.
4. Romani, N., S. Ebner, C. H. Tripp, V. Flacher, F. Koch, and P. Stoitzner. 2006. Epidermal Langerhans cells: changing views on their function in vivo. Immunol. Lett. 106: 119-125.
5. Kaplan, D. H., A. Kissenpfennig, and B. E. Clausen. 2008. Insights into Langerhans cell function from Langerhans cell ablation models. Eur. J. Immunol. 38: 2369-2376.
6. Kissenpfennig, A., S. Henri, B. Dubois, C. Laplace-Builhe, P. Perrin, N. Romani, C. H. Tripp, P. Douillard, L. Leserman, D. Kaiserlian, et al. 2005. Dynamics and function of Langerhans cells in vivo dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22: 643-654.
7. Bennett, C. L., E. van Rijn, S. Jung, K. Inaba, R. M. Steinman, M. L. Kapsenberg, and B. E. Clausen. 2005. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J. Cell Biol. 169: 569-576.
8. + dendritic cells. J. Exp. Med. 204: 3147-3156.
9. + dendritic cells survey the skin in the steady state. J. Exp. Med. 204: 3133-3146.
10. + dendritic cells that develop and function independently of epidermal Langerhans cells. J. Exp. Med. 204: 3119-3131.
11. Valladeau, J., V. Clair-Moninot, C. Dezutter-Dambuyant, J. J. Pin, A. Kissenpfennig, M. G. Mattei, S. Ait-Yahia, E. E. Bates, B. Malissen, F. Koch, et al. 2002. Identification of mouse langerin/CD207 in Langerhans cells and some dendritic cells of lymphoid tissues. J. Immunol. 168: 782-792.
12. Douillard, P., P. Stoitzner, C. H. Tripp, V. Clair-Moninot, S. Ait-Yahia, A. D. McLellan, A. Eggert, N. Romani, and S. Saeland. 2005. Mouse lymphoid tissue contains distinct subsets of langerin/CD207 dendritic cells, only one of which represents epidermal-derived Langerhans cells. J. Invest. Dermatol. 125: 983-994.
13. Bennett, C. L., M. Noordegraaf, C. A. Martina, and B. E. Clausen. 2007. Langerhans cells are required for efficient presentation of topically applied hapten to T cells. J. Immunol. 179: 6830-6835.
14. Kaplan, D. H., M. C. Jenison, S. Saeland, W. D. Shlomchik, and M. J. Shlomchik. 2005. Epidermal langerhans cell-deficient mice develop enhanced contact hyper-sensitivity. Immunity 23: 611-620.
15. Obhrai, J. S., M. Oberbarnscheidt, N. Zhang, D. L. Mueller, W. D. Shlomchik, F. G. Lakkis, M. J. Shlomchik, and D. H. Kaplan. 2008. Langerhans cells are not required for efficient skin graft rejection. J. Invest. Dermatol. 128: 1950-1955.
16. Vesely, D. L., D. Fish, M. J. Shlomchik, D. H. Kaplan, and L. K. Bockenstedt. 2009. Langerhans cell deficiency impairs Ixodes scapularis suppression of Th1 responses in mice. Infect. Immun. 77: 1881-1887.
17. + T cells. J. Exp. Med. 183: 1001-1012.
18. + IL-17-producing T cells are important in effector functions for the elicitation of contact hypersensitivity responses. J. Immunol. 177: 6852-6858.
19. Nakae, S., Y. Komiyama, A. Nambu, K. Sudo, M. Iwase, I. Homma, K. Sekikawa, M. Asano, and Y. Iwakura. 2002. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17: 375-387.
20. + T cell-mediated contact hypersensitivity. J. Exp. Med. 189: 779-786.
21. + T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene. Eur. J. Immunol. 25: 3006-3010.
22. + T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. J. Immunol. 144: 4121-4128.
23. Watanabe, H., M. Unger, B. Tuvel, B. Wang, and D. N. Sauder. 2002. Contact hypersensitivity: the mechanism of immune responses and T cell balance. J. Interferon Cytokine Res. 22: 407-412. (Pubitemid 34579542)
24. + type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity. J. Immunol. 165: 6783-6790.
25. + T cell-mediated cutaneous immune responses by restricting effector T cell development through a Fas ligand-dependent mechanism. J. Immunol. 172: 2286-2295.
26. Loser, K., W. Hansen, J. Apelt, S. Balkow, J. Buer, and S. Beissert. 2005. In vitro-generated regulatory T cells induced by Foxp3-retrovirus infection control murine contact allergy and systemic autoimmunity. Gene Ther. 12: 1294-1304.
27. + T cells mediating skin inflammation. Blood 102: 3295-3301.
28. Kaplan, D. H., M. O. Li, M. C. Jenison, W. D. Shlomchik, R. A. Flavell, and M. J. Shlomchik. 2007. Autocrine/paracrine TGFβ1 is required for the development of epidermal Langerhans cells. J. Exp. Med. 204: 2545-2552.
29. Shimoda, M., F. Mmanywa, S. K. Joshi, T. Li, K. Miyake, J. Pihkala, J. A. Abbas, and P. A. Koni. 2006. Conditional ablation of MHC-II suggests an indirect role for MHC-II in regulatory CD4 T cell maintenance. J. Immunol. 176: 6503-6511. (Pubitemid 43787832)
30. Roers, A., L. Siewe, E. Strittmatter, M. Deckert, D. Schluter, W. Stenzel, A. D. Gruber, T. Krieg, K. Rajewsky, and W. Muller. 2004. T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation. J. Exp. Med. 200: 1289-1297.
31. Openshaw, P., E. E. Murphy, N. A. Hosken, V. Maino, K. Davis, K. Murphy, and A. O'Garra. 1995. Heterogeneity of intracellular cytokine synthesis at the singlecell level in polarized T helper 1 and T helper 2 populations. J. Exp. Med. 182: 1357-1367.
32. + regulatory T cells maintain immune homeostasis in the skin. J. Exp. Med. 205: 1559-1565.
33. + regulatory T cells results in tissue-specific inflammatory disease. J. Exp. Med. 204: 1335-1347.
34. Yoshiki, R., K. Kabashima, K. Sugita, K. Atarashi, T. Shimauchi, and Y. Tokura. 2009. IL-10-producing Langerhans cells and regulatory T cells are responsible for depressed contact hypersensitivity in grafted skin. J. Invest. Dermatol. 129: 705-713.
35. Flacher, V., M. Bouschbacher, E. Verronese, C. Massacrier, V. Sisirak, O. Berthier-Vergnes, B. de Saint-Vis, C. Caux, C. Dezutter-Dambuyant, S. Lebecque, and J. Valladeau. 2006. Human Langerhans cells express a specific TLR profile and differentially respond to viruses and Gram-positive bacteria. J. Immunol. 177: 7959-7967.
36. + T cell responses elicited by different subsets of human skin migratory dendritic cells. J. Immunol. 175: 7905-7915.
37. Moore, K. W., R. de Waal Malefyt, R. L. Coffman, and A. O'Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19: 683-765.
38. Cella, M., D. Scheidegger, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia, and G. Alber. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184: 747-752.
39. Shibaki, A., and S. I. Katz. 2001. Activation through CD40 ligation induces functional Fas ligand expression by Langerhans cells. Eur. J. Immunol. 31: 3006-3015.
40. Wang, B., L. Zhuang, H. Fujisawa, G. A. Shinder, C. Feliciani, G. M. Shivji, H. Suzuki, P. Amerio, P. Toto, and D. N. Sauder. 1999. Enhanced epidermal Langerhans cell migration in IL-10 knockout mice. J. Immunol. 162: 277-283. (Pubitemid 29018930)
41. Henri, S., D. Vremec, A. Kamath, J. Waithman, S. Williams, C. Benoist, K. Burnham, S. Saeland, E. Handman, and K. Shortman. 2001. The dendritic cell populations of mouse lymph nodes. J. Immunol. 167: 741-748.
42. Merad, M., F. Ginhoux, and M. Collin. 2008. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat. Rev. Immunol. 8: 935-947.
43. Marrack, P., and J. Kappler. 2004. Control of T cell viability. Annu. Rev. Immunol. 22: 765-787.
44. Yoshida, R., T. Imai, K. Hieshima, J. Kusuda, M. Baba, M. Kitaura, M. Nishimura, M. Kakizaki, H. Nomiyama, and O. Yoshie. 1997. Molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7. J. Biol. Chem. 272: 13803-13809.
45. von Bubnoff, D., H. Bausinger, H. Matz, S. Koch, G. Hacker, O. Takikawa, T. Bieber, D. Hanau, and H. de la Salle. 2004. Human epidermal Langerhans cells express the immunoregulatory enzyme indoleamine 2,3-dioxygenase. J. Invest. Dermatol. 123: 298-304.
46. + T cells during the development of contact hypersensitivity responses. Immunol. Res. 24: 69-77.
47. + regulatory T cells suppress contact hypersensitivity reactions by blocking influx of effector T cells into inflamed tissue. Eur. J. Immunol. 36: 2981-2992.
48. Loser, K., A. Mehling, S. Loeser, J. Apelt, A. Kuhn, S. Grabbe, T. Schwarz, J. M. Penninger, and S. Beissert. 2006. Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat. Med. 12: 1372-1379.
49. Nagao, K., F. Ginhoux, W. W. Leitner, S. Motegi, C. L. Bennett, B. E. Clausen, M. Merad, and M. C. Udey. 2009. Murine epidermal Langerhans cells and Langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions. Proc. Natl. Acad. Sci. USA 106: 3312-3317.
50. Tang, A., T. A. Judge, B. J. Nickoloff, and L. A. Turka. 1996. Suppression of murine allergic contact dermatitis by CTLA4Ig: tolerance induction of Th2 responses requires additional blockade of CD40-ligand. J. Immunol. 157: 117-125. (Pubitemid 26190538)